Publications by authors named "Evan Yu"

Claim this Profile
N
Neoadjuvant Pembrolizumab and Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Nonurothelial Histologic Subtypes of Muscle-invasive Bladder Cancer: A Phase 2 Trial.
Ruben Raychaudhuri, Ali Raza Khaki, Mary W Redman, Kelsey K Baker, Kevin Ng, Evan Y Yu

Eur Urol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Agreement between transurethral resection of bladder tumor and radical cystectomy pathology in patients with bladder cancer subtype histology: A retrospective cohort study.
Dimitra Rafailia Bakaloudi, Elizabeth L Koehne, Jenna M Voutsinas, Leonidas Ν Diamantopoulos, Dimitrios Makrakis, Evan Y Yu

Urol Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design Considerations.
David J Einstein, Melissa L Abel, Jeanny B Aragon-Ching, Philip M Arlen, Karen A Autio, Evan Y Yu

J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integration of gut microbiome and lipid metabolism reveals the anti-cancer effects of pentadecanoic acid on bladder cancer.
Ya-Ting Chen, Jing Sui, Yu Yang, Hao Zhang, Anke Wesselius, Evan Yi-Wen Yu

BMC Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Trial in Progress: SWOG S2210, a Phase 2 Study of Neoadjuvant Carboplatin for Localized High-risk Prostate Cancer with Germline BRCA1/2 Mutations.
Heather H Cheng, Sam Callis, Evan Y Yu, Scott E Delacroix, Alexandra O Sokolova

Eur Urol Focus· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline and Somatic Genomic Testing for Metastatic Prostate Cancer: ASCO Guideline Clinical Insights.
Veda N Giri, R Bryan Rumble, Evan Y Yu, Kevin Lu

JCO Oncol Pract· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug Targets in Prostate Cancer: An Appetite for KLK2-Mediated Destruction.
Steven Blinka, Evan Y Yu

Clin Cancer Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring multimodal large language models on transthoracic Echocardiogram (TTE) tasks for cardiovascular decision support.
Jianfu Li, Yiming Li, Zenan Sun, Evan Yu, Ahmed M Abdelhameed, Yue Yu, Xinyue Hu

J Biomed Inform· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DARolutamide ObservationaL (DAROL) study in patients with nonmetastatic castration-resistant prostate cancer: prespecified third interim analysis.
Evan Y Yu, Hiroyoshi Suzuki, Christopher M Pieczonka, Geoffrey Gotto, Alberto Briganti

Prostate Cancer Prostatic Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early and Precise: Treating HRR Alterations in Hormone-Sensitive Prostate Cancer.
Laura S Graham, Evan Y Yu

Clin Cancer Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to "Proteomic Profiling of Urinary Large Extracellular Vesicles for the Diagnosis of Prostate Cancer".
Yu-Ping Fan, Yu-Ting Zhang, Guiyuan Zhang, Le Ma, Ying Lv, Yulian Luan, Yu-Xuan Wu, Evan Yi-Wen Yu

Anal Chem· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective evaluation of comprehensive geriatric assessments in multidisciplinary bladder cancer care and implications for personalized vulnerability phenotyping.
Dana Cavanaugh, Sarah K Holt, Erin Dwyer, Erin Petersen, John L Gore, Evan Y Yu

Urol Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response and Survival With Immune Checkpoint Inhibitor in Patients With Advanced Urothelial Carcinoma and Histology Subtypes.
Dimitra Rafailia Bakaloudi, Rafee Talukder, Thomas Enright, Jacob B Leary, Dimitrios Makrakis, Evan Y Yu

Clin Genitourin Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of SPECT/CT in 177 Lu-PSMA-617 Theranostics: Case-based Review of Response and Progression Patterns.
Alireza Ghodsi, Ridvan Arda Demirci, Delphine L Chen, Peter S Nelson, Michael T Schweizer, Evan Y Yu

Clin Nucl Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of intra- and intertumor phenotypic heterogeneity in lethal prostate cancer.
Martine P Roudier, Roman Gulati, Erolcan Sayar, Radhika A Patel, Micah Tratt, Evan Y Yu

J Clin Invest· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The associations between sleep-related factors and bladder cancer: A cross-sectional study in the UK Biobank.
Yiming Chen, Enyu Tong, Yufeng Rao, Evan Yw Yu, Yating Chen

Cancer Epidemiol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic Profiling of Urinary Large Extracellular Vesicles for the Diagnosis of Prostate Cancer.
Yu-Ping Fan, Yu-Ting Zhang, Guiyuan Zhang, Le Ma, Ying Lv, Yulian Luan, Yu-Xuan Wu, Evan Yi-Wen Yu

Anal Chem· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported Outcomes in KEYLYNK-010: Pembrolizumab Plus Olaparib Versus Abiraterone or Enzalutamide for Participants with Biomarker-unselected, Previously Treated Metastatic Castration-resistant Prostate Cancer.
Niven Mehra, Emmanuel S Antonarakis, Se Hoon Park, Jeffrey C Goh, Ray McDermott, Evan Y Yu

Eur Urol Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers: Implications for HER2-Targeted Therapies.
Hyun Jung Lee, Roman Gulati, Erolcan Sayar, Radhika A Patel, Pushpa Itagi, Evan Y Yu

Cancer Res Commun· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interaction between coffee consumption and polygenic risk score in relation to diabetes: insights from the Maastricht study.
Yufeng Rao, Evan Yi-Wen Yu, Tzu-Yao Lin, Yiming Chen, Yingfen Qin

Eur J Nutr· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Smartphone-Measured Heart Sounds for Atrial Fibrillation Screening in Community Populations.
Huiying Ren, Qirong Qin, Quanbin Dong, Aikeliyaer Ainiwaer, Hongmei Yuan, Evan Yi-Wen Yu

Circulation· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association between diet and bladder cancer risk: a two-sample mendelian randomization.
Ya-Nan Dai, Evan Yi-Wen Yu, Maurice P Zeegers, Anke Wesselius

Eur J Nutr· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Association between Tea Consumption and Bladder Cancer Risk Based on the Bladder Cancer Epidemiology and Nutritional Determinants (BLEND) International Consortium.
Yan-Xi Zhang, Richard Albers, Ya-Ting Chen, Gunnar Steineck, Eliane Kellen, Evan Yi-Wen Yu

Nutr Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results from a Phase 2 Study of Induction Docetaxel and Carboplatin Followed by Maintenance Rucaparib in the Treatment of Patients with Metastatic Castration-resistant Prostate Cancer with DNA Homologous Recombination Repair Deficiency.
Ruben Raychaudhuri, Heather H Cheng, Roman Gulati, Michael T Schweizer, Aaron Lin, Evan Y Yu

Eur Urol Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cohort Profile: TRacing Etiology of Non-communicable Diseases (TREND): Rationale, Progress and Perspective.
Hui-Ying Ren, Ying Lv, Bei-Ning Ma, Chang Gao, Hong-Mei Yuan, Yu-Ting Zhang, Yu-Ping Fan, Yu-Xuan Wu, Zhuo-Yue Feng, Evan Yi-Wen Yu

Phenomics· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis